Improve Medical Instruments Co., Ltd. (300030.SZ)
CNY 5.41
(0.0%)
CNY 5.41
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 11.49 Million CNY | -64.14% |
| 2022 | 32.05 Million CNY | -30.61% |
| 2021 | 46.2 Million CNY | -77.91% |
| 2020 | 209.12 Million CNY | 720.11% |
| 2019 | 25.5 Million CNY | -92.13% |
| 2018 | 323.87 Million CNY | -26.09% |
| 2017 | 438.22 Million CNY | 645.78% |
| 2016 | 58.76 Million CNY | -20.05% |
| 2015 | 73.5 Million CNY | 267.5% |
| 2014 | 20 Million CNY | 0.0% |
| 2013 | - CNY | 0.0% |
| 2012 | - CNY | 0.0% |
| 2011 | - CNY | 0.0% |
| 2010 | - CNY | -100.0% |
| 2009 | 16 Million CNY | -8.57% |
| 2008 | 17.5 Million CNY | 0.0% |
| 2007 | - CNY | 0.0% |
| 2006 | - CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 17.65 Million CNY | 119.49% |
| 2024 Q2 | 27.58 Million CNY | 109.5% |
| 2024 Q3 | 34.44 Million CNY | 24.85% |
| 2023 Q3 | 28.27 Million CNY | 3.8% |
| 2023 Q4 | 11.49 Million CNY | -59.35% |
| 2023 Q2 | 27.24 Million CNY | -14.72% |
| 2023 Q1 | 31.94 Million CNY | -0.35% |
| 2023 FY | 11.49 Million CNY | -64.14% |
| 2022 Q1 | 43.2 Million CNY | -6.48% |
| 2022 Q3 | 37.58 Million CNY | -2.98% |
| 2022 Q4 | 32.05 Million CNY | -14.7% |
| 2022 FY | 32.05 Million CNY | -30.61% |
| 2022 Q2 | 38.73 Million CNY | -10.35% |
| 2021 Q2 | 13.86 Million CNY | -94.11% |
| 2021 Q3 | 11.97 Million CNY | -13.61% |
| 2021 FY | 46.2 Million CNY | -77.91% |
| 2021 Q1 | 235.45 Million CNY | 12.59% |
| 2021 Q4 | 46.2 Million CNY | 285.71% |
| 2020 Q2 | 229.96 Million CNY | 801.82% |
| 2020 Q4 | 209.12 Million CNY | -9.28% |
| 2020 Q3 | 230.51 Million CNY | 0.24% |
| 2020 FY | 209.12 Million CNY | 720.11% |
| 2020 Q1 | 25.5 Million CNY | 0.0% |
| 2019 Q4 | 25.5 Million CNY | -92.15% |
| 2019 FY | 25.5 Million CNY | -92.13% |
| 2019 Q1 | 322.05 Million CNY | -0.56% |
| 2019 Q2 | 326.18 Million CNY | 1.28% |
| 2019 Q3 | 324.73 Million CNY | -0.44% |
| 2018 FY | 323.87 Million CNY | -26.09% |
| 2018 Q4 | 323.87 Million CNY | 4.66% |
| 2018 Q3 | 309.46 Million CNY | -1.6% |
| 2018 Q2 | 314.48 Million CNY | -25.62% |
| 2018 Q1 | 422.83 Million CNY | -3.51% |
| 2017 Q1 | 156.26 Million CNY | 165.93% |
| 2017 FY | 438.22 Million CNY | 645.78% |
| 2017 Q4 | 438.22 Million CNY | -0.63% |
| 2017 Q3 | 441.01 Million CNY | -0.2% |
| 2017 Q2 | 441.9 Million CNY | 182.8% |
| 2016 Q3 | 66 Million CNY | -3.65% |
| 2016 Q2 | 68.5 Million CNY | -6.8% |
| 2016 Q1 | 73.5 Million CNY | 0.0% |
| 2016 FY | 58.76 Million CNY | -20.05% |
| 2016 Q4 | 58.76 Million CNY | -10.97% |
| 2015 Q4 | 73.5 Million CNY | 47.0% |
| 2015 Q1 | 20 Million CNY | 0.0% |
| 2015 FY | 73.5 Million CNY | 267.5% |
| 2015 Q3 | 50 Million CNY | 150.0% |
| 2015 Q2 | 20 Million CNY | 0.0% |
| 2014 FY | 20 Million CNY | 0.0% |
| 2014 Q4 | 20 Million CNY | 0.0% |
| 2014 Q3 | 20 Million CNY | 100.0% |
| 2014 Q2 | 10 Million CNY | 0.0% |
| 2014 Q1 | - CNY | 0.0% |
| 2013 Q4 | - CNY | 0.0% |
| 2013 FY | - CNY | 0.0% |
| 2013 Q1 | - CNY | 0.0% |
| 2013 Q2 | - CNY | 0.0% |
| 2013 Q3 | - CNY | 0.0% |
| 2012 Q1 | - CNY | 0.0% |
| 2012 Q2 | - CNY | 0.0% |
| 2012 Q4 | - CNY | 0.0% |
| 2012 FY | - CNY | 0.0% |
| 2012 Q3 | - CNY | 0.0% |
| 2011 Q2 | - CNY | 0.0% |
| 2011 FY | - CNY | 0.0% |
| 2011 Q4 | - CNY | 0.0% |
| 2011 Q1 | - CNY | 0.0% |
| 2011 Q3 | - CNY | 0.0% |
| 2010 Q3 | - CNY | 0.0% |
| 2010 Q2 | - CNY | 0.0% |
| 2010 Q1 | - CNY | -100.0% |
| 2010 FY | - CNY | -100.0% |
| 2010 Q4 | - CNY | 0.0% |
| 2009 Q2 | 22.5 Million CNY | 0.0% |
| 2009 Q3 | 28.75 Million CNY | 27.78% |
| 2009 Q4 | 16 Million CNY | -44.35% |
| 2009 FY | 16 Million CNY | -8.57% |
| 2008 Q4 | 17.5 Million CNY | 0.0% |
| 2008 FY | 17.5 Million CNY | 0.0% |
| 2007 FY | - CNY | 0.0% |
| 2006 FY | - CNY | 0.0% |